Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Coast To Coast Tribune.
Press releases published on June 6, 2025
Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million
GlobeNewswire
·
June 6, 2025
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG …
AYR Provides Update on Anticipated Cease Trade Order
GlobeNewswire
·
June 6, 2025
MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today provides an update regarding the status of its securities in …
Race to the road: Introducing the Porsche 963 RSP
GlobeNewswire
·
June 6, 2025
Le Mans, June 06, 2025 (GLOBE NEWSWIRE) -- As Porsche prepares for the 24 Hours of Le Mans, a sister to the 963 Hypercar has been revealed – named the 963 RSP. An extreme one-off based on the IMSA championship and WEC championship winning machine, the car …
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
GlobeNewswire
·
June 6, 2025
– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 …
OTC Markets Group Welcomes Neo Performance Materials Inc to OTCQX
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Neo Performance Materials Inc (TSX: NEO; OTCQX: NOPMF), a manufacturer of …
G-III Apparel Group, Ltd. Reports First Quarter Fiscal 2026 Results
GlobeNewswire
·
June 6, 2025
Net Income Per Diluted Share of $0.17 for the First Quarter Compared to $0.12 Last Year and Non-GAAP Net Income Per Diluted Share of $0.19 for the First Quarter Compared to $0.12 Last Year, Both Exceeding Guidance Net Sales of $583.6 Million for the First …
BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries
GlobeNewswire
·
June 6, 2025
RESEARCH TRIANGLE PARK, N.C., June 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO® (berotralstat) has been approved for the …
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
GlobeNewswire
·
June 6, 2025
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory Board to …
RYVYL Announces Conversion for Remainder of 8% Senior Convertible Note; Successfully Completes Process of Delevering Balance Sheet
GlobeNewswire
·
June 6, 2025
SAN DIEGO, CA, June 06, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a leading innovator of payment transaction solutions leveraging electronic payment technology, announced the securityholder of its remaining 8% Senior …
Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression
GlobeNewswire
·
June 6, 2025
- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo’s CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 (liafensine) in treatment-resistant depression (TRD) - SAN …
Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
GlobeNewswire
·
June 6, 2025
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
ABM Reports Fiscal Second Quarter 2025 Results
GlobeNewswire
·
June 6, 2025
Revenue up 4.6% to $2.1 billion, with organic growth contributing 3.8% Business …
Deep Isolation Joins International WISARD Initiative to Build Integrated Waste Solutions for a Sustainable Nuclear Future
GlobeNewswire
·
June 6, 2025
BERKELEY, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Deep Isolation, a leading innovator in nuclear waste disposal technology, today announced its participation in the newly launched WISARD (Waste Integration for Small and Advanced Reactor Designs), a three …
Ferrellgas Partners, L.P. Reports Third Quarter Fiscal Year 2025 Results
GlobeNewswire
·
June 6, 2025
LIBERTY, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2025 third fiscal quarter ended April 30, 2025. Tamria Zertuche, President and Chief Executive …
Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025
GlobeNewswire
·
June 6, 2025
Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 …
Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne
GlobeNewswire
·
June 6, 2025
AMSTERDAM, 06 juin 2025 (GLOBE NEWSWIRE) -- Polpharma Group, fabricant européen de produits pharmaceutiques de premier plan, s’est joint aux autres membres de l’association Medicines for Europe pour signer une lettre ouverte adressée aux Premiers ministres …
Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas
GlobeNewswire
·
June 6, 2025
AMSTERDAM, June 06, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führender europäischer Pharmahersteller, hat sich anderen Mitgliedern von Medicines for Europe angeschlossen und einen offenen Brief an die Premierminister und Gesundheitsminister aller …
Online Taxman Recognized at Prestigious 2025 FEM EMMA Awards In Recognition of Innovation and Excellence
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Leading online expatriate tax services provider Online Taxman has received the Highly Commended award in the Best Banking, Tax or Financial Services Provider of the Year category at the prestigious 2025 FEM EMMA …
クラウデラ (Cloudera)、AI-RANアライアンスに加盟し、リアルタイムデータの革新とAIネイティブな通信分野の発展を推進
GlobeNewswire
·
June 6, 2025
カリフォルニア州サンタクララ発, June 06, 2025 (GLOBE NEWSWIRE) -- データ、分析、AIのための唯一の真のハイブリッドプラットフォームであるクラウデラは本日、AIを通信インフラに統合することを目的とした国際的なコンソーシアムであるAI-RANアライアンスに加盟したことを発表した。 クラウデラは、AI-RANの推進と、通信ネットワークをリアルタイムデータとAIによって知能化された収益創出型プラットフォームへと変革することを目的に、データとAI …
Cloudera, 실시간 데이터 혁신 및 AI 네이티브 통신 추진을 위해 AI-RAN Alliance에 합류
GlobeNewswire
·
June 6, 2025
산타클라라, 캘리포니아, June 06, 2025 (GLOBE NEWSWIRE) -- 데이터, 애널리틱스, AI 활용을 위한 하이브리드 유일 플랫폼 Cloudera가 통신 인프라에 AI 통합을 추진 중인 글로벌 컨소시엄인 AI-RAN Alliance에 가입했다고 오늘 발표했다. Cloudera는 AI-RAN 어젠다를 추진하는 한편 통신 네트워크를 실시간 데이터와 AI를 통해 지능형 수익 창출 플랫폼으로 전환하는 데 주력하는 데이터 및 AI 관련 기업들과 …